中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2014年
13期
1921-1924
,共4页
刘季芳%邓敏%尹江%贺智敏
劉季芳%鄧敏%尹江%賀智敏
류계방%산민%윤강%하지민
二甲双胍%肝肿瘤%细胞衰老%细胞凋亡
二甲雙胍%肝腫瘤%細胞衰老%細胞凋亡
이갑쌍고%간종류%세포쇠로%세포조망
Metformin%Liver neoplasms%Cell aging%Apoptosis
目的 探讨二甲双胍(Met)对肝癌细胞衰老的影响及其机制.方法 不同浓度(0、0.01、0.1、1、10和50 mmol/L) Met处理肝癌细胞HepG2细胞后,采用MTS法检测细胞增殖情况;流式细胞术检测细胞周期及细胞凋亡改变;通过衰老相关β-半乳糖苷酶(SA-β-ga1)染色和衰老标记分子Dec1蛋白表达分析Met对细胞衰老的影响;蛋白质印迹法分析p-AMPK、p-ACC和AMPK蛋白的表达.结果 Met可以抑制HepG2细胞的增殖,且呈浓度依赖性;高浓度(10和50 mmol/L)Met促进肝癌细胞凋亡;低浓度(0.01、0.1和1 mmol/L) Met作用后,肝癌细胞呈现典型的大而扁平的衰老形态,SA-β-ga1染色阳性细胞显著增多,细胞周期停滞于G0/G1期,衰老标记分子Dec1蛋白表达明显上调.此外,低浓度Met可以促进p-AMPK和p-ACC蛋白表达,而对AMPK蛋白表达无明显影响.结论 高浓度Met促进肝癌细胞凋亡;低浓度Met则诱导肝癌细胞衰老,其作用机制可能与激活AMPK信号通路有关.该研究为以后利用诱导肝癌细胞衰老这种方式提高肝癌综合治疗水平,提供了重要实验依据.
目的 探討二甲雙胍(Met)對肝癌細胞衰老的影響及其機製.方法 不同濃度(0、0.01、0.1、1、10和50 mmol/L) Met處理肝癌細胞HepG2細胞後,採用MTS法檢測細胞增殖情況;流式細胞術檢測細胞週期及細胞凋亡改變;通過衰老相關β-半乳糖苷酶(SA-β-ga1)染色和衰老標記分子Dec1蛋白錶達分析Met對細胞衰老的影響;蛋白質印跡法分析p-AMPK、p-ACC和AMPK蛋白的錶達.結果 Met可以抑製HepG2細胞的增殖,且呈濃度依賴性;高濃度(10和50 mmol/L)Met促進肝癌細胞凋亡;低濃度(0.01、0.1和1 mmol/L) Met作用後,肝癌細胞呈現典型的大而扁平的衰老形態,SA-β-ga1染色暘性細胞顯著增多,細胞週期停滯于G0/G1期,衰老標記分子Dec1蛋白錶達明顯上調.此外,低濃度Met可以促進p-AMPK和p-ACC蛋白錶達,而對AMPK蛋白錶達無明顯影響.結論 高濃度Met促進肝癌細胞凋亡;低濃度Met則誘導肝癌細胞衰老,其作用機製可能與激活AMPK信號通路有關.該研究為以後利用誘導肝癌細胞衰老這種方式提高肝癌綜閤治療水平,提供瞭重要實驗依據.
목적 탐토이갑쌍고(Met)대간암세포쇠로적영향급기궤제.방법 불동농도(0、0.01、0.1、1、10화50 mmol/L) Met처리간암세포HepG2세포후,채용MTS법검측세포증식정황;류식세포술검측세포주기급세포조망개변;통과쇠로상관β-반유당감매(SA-β-ga1)염색화쇠로표기분자Dec1단백표체분석Met대세포쇠로적영향;단백질인적법분석p-AMPK、p-ACC화AMPK단백적표체.결과 Met가이억제HepG2세포적증식,차정농도의뢰성;고농도(10화50 mmol/L)Met촉진간암세포조망;저농도(0.01、0.1화1 mmol/L) Met작용후,간암세포정현전형적대이편평적쇠로형태,SA-β-ga1염색양성세포현저증다,세포주기정체우G0/G1기,쇠로표기분자Dec1단백표체명현상조.차외,저농도Met가이촉진p-AMPK화p-ACC단백표체,이대AMPK단백표체무명현영향.결론 고농도Met촉진간암세포조망;저농도Met칙유도간암세포쇠로,기작용궤제가능여격활AMPK신호통로유관.해연구위이후이용유도간암세포쇠로저충방식제고간암종합치료수평,제공료중요실험의거.
Objective To explore the effect of metformin on hepatoma cells senescence and the underlying mechanism.Methods Cell proliferation,cycle and apoptosis were examined by MTS and flow cytometry assay in response to different concentrations of metformin(0,0.01,0.1,1,10 and 50mmol/L).Senescence-associated β-galactosidase (SA-β-ga1) staining and senescence marker Dec1 protein levels were used to evaluate the effect of metformin on hepatoma cells senescence.In addition,protein expression of p-AMPK,p-ACC and AMPK was detected by Western blot analysis.Results Metformin suppressed proliferation of HepG2 cells in a dose-dependent manner.High concentrations of metformin (10 and 50mmol/L) promoted cell apoptosis,while lower doses of metformin (0.01,0.1 and 1mmol/L) led to enlarged and flatten senescent morphology and increased SA-β-ga1 positive cells.Moreover,cell cycle was blocked in G0/G1 phase and protein levels of senescent marker Dec1,p-AMPK and p-ACC were significantly enhanced,whereas AMPK protein expression was almost unchanged.Conclusion We showed here that high dose of metformin promotes HepG2 cells apoptosis,but low doses of metformin induce cellular senescence,which may be related to the activation of AMPK signaling.These data will provide vital evidence for improving the outcome of comprehensive treatment in HCC patients by driving hepatoma cells to undergo senescence.